Macleods Pharmaceuticals Limited recalls Olanzapine Tablets
- Published
- 30 Sept 2026
- Units affected
- 22,032 30-count bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.
Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.
- Brand / company
- Macleods Pharmaceuticals Limited
- Codes / lots
- Lot: BOB22321A, Exp 07-31-2027.
- Distribution
- Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 30 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.